Deal Announcements

Horizon Pharma Adds $35 Million From Inside VCs

Monday, January 24, 2011 5:53:00 AM PDT | VentureDeal Staff

Northbrook, Illinois  --  Biopharmaceutical company Horizon Pharma has garnered $35 million in venture capital debt from among its existing investors, according to a report in VentureWire.

Verizon is developing a portfolio of mild to moderate pain management therapies through innovative combinations of existing pharmaceutical products.

Specific investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1